Market research
GNS.LSE Genus plc
LSE GBP Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 1B
- P/E ratio
- 5.09
- Analyst target
- 3039.167
- Dividend yield
- 1.6%
- Beta
- 0.9
Profile
Company facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- GB0002074580
- Market cap
- 1B
- P/E ratio
- 5.09
- Analyst target
- 3039.167
- Dividend yield
- 1.6%
- Beta
- 0.9
About
About Genus plc
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the GNS.LSE discussion.
5 years, 5 months ago
Genus plc is currently in a long term uptrend where the price is trading 9.3% above its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.7.
Genus plc's total revenue sank by 0.0% to $135M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $12M since the same quarter in the previous year.
Finally, its free cash flow grew by 120.0% to $14M since the same quarter in the previous year.
Based on the above factors, Genus plc gets an overall score of 3/5.